(Q33380073)

26 July 2017

1 reference

title

What's new in haemolytic uraemic syndrome? (English)

1 reference

26 July 2017

Sally Johnson

1

1 reference

PubMed ID

18575887

26 July 2017

C Mark Taylor

series ordinal

2

1 reference

26 July 2017

25 June 2008

1 reference

European Journal of Pediatrics

26 July 2017

1 reference

26 July 2017

167

1 reference

26 July 2017

9

1 reference

26 July 2017

965-971

1 reference

https://scigraph.springernature.com/pub.10.1007/s00431-008-0745-7

26 July 2017

0 references

cites work

A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00431-008-0745-7

Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-008-0745-7

Infection by verocytotoxin-producing Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-008-0745-7

Childhood hemolytic uremic syndrome, United Kingdom and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-008-0745-7

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome

21 January 2018

1 reference

12 December 2020

Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study

1 reference

12 December 2020

Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome

1 reference

12 December 2020

Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation

1 reference

12 December 2020

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

1 reference

12 December 2020

Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation

1 reference

12 December 2020

Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms

1 reference

12 December 2020

Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection

1 reference

12 December 2020

Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome

1 reference

12 December 2020

Attempted treatment of factor H deficiency by liver transplantation

1 reference

12 December 2020

Renal functional reserve evolution in children with a previous episode of hemolytic uremic syndrome

1 reference

12 December 2020

Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience

1 reference

12 December 2020

Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants

1 reference

12 December 2020

Genetic studies into inherited and sporadic hemolytic uremic syndrome

1 reference

12 December 2020

Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H.

1 reference

12 December 2020

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries

1 reference

12 December 2020

Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects

1 reference

12 December 2020

Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency

1 reference

12 December 2020

Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features.

1 reference

12 December 2020

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background

1 reference

12 December 2020

Recurrence of HUS due to CD46/MCP mutation after renal transplantation: a role for endothelial microchimerism.

1 reference

12 December 2020

Familial haemolytic uraemic syndrome and an MCP mutation

1 reference

12 December 2020

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

1 reference

12 December 2020

Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions

1 reference

12 December 2020

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

1 reference

12 December 2020

The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.

1 reference

12 December 2020

Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups

1 reference

12 December 2020

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome

1 reference

12 December 2020

Combined kidney and liver transplantation for familial haemolytic uraemic syndrome

1 reference

12 December 2020

The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts

1 reference

12 December 2020

Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9

1 reference

12 December 2020

Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H.

1 reference

12 December 2020

Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?

1 reference

12 December 2020

Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France

1 reference

12 December 2020

The late histologic findings in diarrhea-associated hemolytic uremic syndrome

1 reference

12 December 2020

Enteropathogenic and enterohaemorrhagic Escherichia coli : more subversive elements

1 reference

12 December 2020

Subversion of actin dynamics by EPEC and EHEC.

1 reference

12 December 2020

An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations

1 reference

12 December 2020

Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome

1 reference

12 December 2020

Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis

1 reference

12 December 2020

Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome

1 reference

12 December 2020

Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.

1 reference

12 December 2020

What makes an enterohemorrhagic Escherichia coli?

1 reference

12 December 2020

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion

1 reference

12 December 2020

Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H.

1 reference

12 December 2020

Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome

1 reference

12 December 2020

Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression

1 reference

12 December 2020

Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

1 reference

12 December 2020

Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells

1 reference

12 December 2020

Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition

1 reference

12 December 2020

10.1007/S00431-008-0745-7

Identifiers

DOI

1 reference

PubMed ID

18575887

Dimensions Publication ID

26 July 2017

0 references

1 reference

PubMed ID

18575887